Novartis expands capabilities to execute multinational trials in Korea

Published: 2010-02-26 06:58:00

Updated: 2010-02-26 06:58:00

Global pharmaceutical giant Novartis Inc. has launched a massive assault on the Korean growth market with its growing scientific reputation. Its clinical members hand-pick Korean doctors to lead local clinical tests.

Novatis Korea is conducting a total of 63 clinical studies here this year and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK